Bright Minds Biosciences INC. (DRUG) SEC Filings — 2025

Filings

• Bright Minds Biosciences Files 6-K, Incorporates News Release — 6-K · Nov 17, 2025
• Bright Minds Biosciences Files 6-K Report — 6-K · Nov 7, 2025
• Bright Minds Biosciences: BMB-201 Outperforms Sumatriptan — 6-K · Sep 5, 2025
• Bright Minds Biosciences Files Q3 Financials — 6-K · Aug 15, 2025
• Bright Minds Biosciences Files Q2 2025 Financial Update — 6-K · Aug 11, 2025
• Bright Minds Biosciences to Present at Jefferies Healthcare Conference — 6-K · May 28, 2025
• Bright Minds Biosciences Hosts Absence Epilepsy R&D Day — 6-K · May 21, 2025
• Bright Minds Biosciences Reports Positive Study Findings — 6-K · May 14, 2025
• Bright Minds Biosciences Files 6-K, Incorporates News Release — 6-K · Apr 29, 2025
• Bright Minds Biosciences Files 6-K, Incorporates F-3 Registration — 6-K · Mar 5, 2025
• Bright Minds Biosciences to Present at March Healthcare Conferences — 6-K · Feb 24, 2025
• Bright Minds Biosciences Files Q1 Financial Update — 6-K · Feb 14, 2025
• Bright Minds Biosciences Appoints New Chief Medical Officer — 6-K · Jan 8, 2025